Effect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouse

Ophthalmic Research

Volumn 37, Issue 2, 2005, Pages 72-82

  Sarra, G M ^a   Sarra, F G ^a   Schlichtenbrede, F C ^b   Trittibach, P ^a   Estermann, S ^a   Tsiroukis, E ^c   Ali, R R ^b   Luthert, P J ^b   Reichel, M B ^c  

^a University Eye Clinic Bern   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Acetylsalicylate; Bystander damage; Microglia; Neuroprotection; Neurotoxicity; Prednisolone; Retinal degeneration

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CASPASE 3; ENZYME ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID; CASP3 PROTEIN, MOUSE; CASPASE; DIFFERENTIATION ANTIGEN; GLUCOCORTICOID; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL DEGENERATION; CONTROLLED STUDY; CRYOPROTECTION; DISEASE COURSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DEGENERATION; STATISTICAL SIGNIFICANCE; WILD TYPE; ANIMAL; CBA MOUSE; CELL MOTION; CONFOCAL MICROSCOPY; ENZYME IMMUNOASSAY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, DIFFERENTIATION; APOPTOSIS; ASPIRIN; CASPASE 3; CASPASES; CELL COUNT; CELL MOVEMENT; GLUCOCORTICOIDS; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED CBA; MICE, MUTANT STRAINS; MICROGLIA; MICROSCOPY, CONFOCAL; PHOTORECEPTORS, VERTEBRATE; PREDNISOLONE; RETINAL DEGENERATION;

EID: 19644393698     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084248     Document Type: Article

References (61)

1. Travis GH: Mechanisms of cell death in the inherited retinal degenerations. Am J Hum Genet 1998;62:503-508.
2. Sanyal S, Zeilmaker GH: Development and degeneration of retina in rds mutant mice: Light and electron microscopic observations in experimental chimaeras. Exp Eye Res 1984;39: 231-246.
3. Huang PC, Gaitan AE, Hao Y, Petters RM, Wong F: Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc Natl Acad Sci USA 1993;90:8484-8488.
4. Kedzierski W, Bok D, Travis GH: Non-cell-autonomous photoreceptor degeneration in rds mutant mice mosaic for expression of a rescue transgene. J Neurosci 1998;18:4076-4082.
5. Hughes EH, Schlichtenbrede FC, Murphy CC, Sarra GM, Luthert PJ, Ali RR, Dick AD: Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest Ophthalmol Vis Sci 2003;44:2229-2234.
6. Provis JM, Penfold PL, Edwards AJ, van Driel D: Human retinal microglia: Expression of immune markers and relationship to the glia limitans. Glia 1995;14:243-256.
7. Flavin MP, Coughlin K, Ho LT: Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 1997;80: 437-448.
8. Streit WJ, Walter SA, Pennell NA: Reactive microgliosis. Prog Neurobiol 1999;57:563-581.
9. Aschner M, Allen JW, Kimelberg HK, LoPachin RM, Streit WJ: Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 1999;39:151-173.
10. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S, Mamada H, Tanaka K, Parada LF, Wada K: Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002;22:9228-9236.
11. Roque RS, Imperial CJ, Caldwell RB: Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 1996;37:196-203.
12. Dick AD, Carter D, Robertson M, Broderick C, Hughes E, Forrester JV, Liversidge J: Control of myeloid activity during retinal inflammation. J Leukoc Biol 2003;74:161-166.
13. Gupta N, Brown KE, Milam AH: Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 2003;76:463-471.
14. Rao NA, Kimoto T, Zamir E, Giri R, Wang R, Ito S, Pararajasegaram G, Read RW, Wu GS: Pathogenic role of retinal microglia in experimental uveoretinitis. Invest Ophthalmol Vis Sci 2003;44:22-31.
15. Zhang C, Tso MO: Characterization of activated retinal microglia following optic axotomy. J Neurosci Res 2003;73:840-845.
16. Thanos S: The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina. Eur J Neurosci 1991;3:1189-1207.
17. Thanos S, Mey J, Wild M: Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 1993;13:455-466.
18. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
19. McGeer PL, McGeer EG: Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001;22:799-809.
20. Barron KD: The microglial cell. A historical review. J Neurol Sci 1995;134(suppl):57-68.
21. Streit WJ: Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002;40:133-139.
22. Dick AD, Carter D, Robertson M, Broderick C, Hughes E, Forrester JV, Liversidge J: Control of myeloid activity during retinal inflammation. J Leukoc Biol 2003;74:161-166.
23. Harada T, Harada C, Nakayama N, Okuyama S, Yoshida K, Kohsaka S, Matsuda H, Wada K: Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 2000;26:533-541.
24. Pairet M, Engelhardt G: Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996;10:1-17.
25. Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Haerter PJ, Bauer J, Fiebich BL: Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 1997;243:726-731.
26. Khayyam N, Thavendiranathan P, Carmichael FJ, Kus B, Jay V, Burnham WM: Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. Neuroreport 1999;10:371-374.
27. Ju WK, Kim KY, Neufeld AH: Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 2003;77:137-145.
28. Kyrkanides S, Moore AH, Olschowka JA, Daeschner JC, Williams JP, Hansen JT, Kerry OM: Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res 2002;104:159-169.
29. Acarin L, Gonzalez B, Castellano B: Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 2002;33:2499-2505.
30. Klegeris A, McGeer PL: Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 2002;23:787-794.
31. Teismann P, Tieu K, Choi D K, Wu D C, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S: Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 2003;100:5473-5478.
32. Consilvio C, Vincent AM, Feldman EL: Neuroinflammation, COX-2, and ALS - A dual role? Exp Neurol 2004;187:1-10.
33. Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O: Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflammation 2004;1:6.
34. Minghetti L, Nicolini A, Polazzi E, Greco A, Perretti M, Parente L, Levi G: Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol 1999;126:1307-1314.
35. Chang JY, Liu LZ: Inhibition of microglial nitric oxide production by hydrocortisone and glucocorticoid precursors. Neurochem Res 2000;25:903-908.
36. Drew PD, Chavis JA: Inhibition of microglial cell activation by cortisol. Brain Res Bull 2000; 52:391-396.
37. McKnight AJ, Macfarlane AJ, Dri P, Turley L, Willis AC, Gordon S: Molecular cloning of F4/ 80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J Biol Chem 1996;271:486-489.
38. McKnight AJ, Gordon S: EGF-TM7: A novel subfamily of seven-transmembrane- region leukocyte cell-surface molecules. Immunol Today 1996;17:283-287.
39. Stacey M, Lin HH, Gordon S, McKnight AJ: LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. Trends Biochem Sci 2000;25:284-289.
40. Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ, McInnes RR: A one-hit model of cell death in inherited neuronal degenerations. Nature 2000;406:195-199.
41. Sapolsky RM: Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1996;1:1-19.
42. Brooke SM, Sapolsky RM. Glucocorticoid exacerbation of gp120 neurotoxicity: Role of microglia. Exp Neurol 2002;177:151-158.
43. Abraham IM, Harkany T, Horvath KM, Luiten PG: Action of glucocorticoids on survival of nerve cells: Promoting neurodegeneration or neuroprotection? J Neuroendocrinol 2001;13:749-760.
44. Flower RJ, Rothwell NJ: Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-76.
45. Mocchetti I, Spiga G, Hayes VY, Isackson PJ, Colangelo A: Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. J Neurosci 1996;16:2141-2148.
46. Nadeau S, Rivest S: Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 2003;23:5536-5544.
47. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ: Growth control of cultured microglia. J Neurosci Res 1992;33:218-230.
48. Jun CD, Hoon R, Um JY, Kim TY, Kim JM, Kang SS, Kim HM, Chung HT: Involvement of protein kinase C in the inhibition of nitric oxide production from murine microglial cells by glucocorticoid. Biochem Biophys Res Commun 1994;199:633-638.
49. Chao CC, Hu S, Close K, Choi CS, Molitor TW, Novick WJ, Peterson PK: Cytokine release from microglia: Differential inhibition by pentoxifylline and dexamethasone. J Infect Dis 1992;166:847-853.
50. Piani D, Fontana A: Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 1994;152:3578-3585.
51. Kiefer R, Kreutzberg GW: Effects of dexamethasone on microglial activation in vivo: Selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus. J Neuroimmunol 1991;34:99-108.
52. Amin R, Kamitani H, Sultana H, Taniura S, Islam A, Sho A, Ishibashi M, Eling TE, Watanabe T: Aspirin and indomethacin exhibit anti-proliferative effects and induce apoptosis in T98G human glioblastoma cells. Neurol Res 2003;25:370-376.
53. Oh KW, Qian T, Brenner DA, Lemasters JJ: Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol Sci 2003;73:44-52.
54. Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S: Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells. J Pharm Pharmacol 2002;54:1675-1679.
55. Zhou XM, Wong BC, Fan XM, Zhang HB, Lin MC, Kung HF, Fan DM, Lam SK: Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 2001;22:1393-1397.
56. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR: Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2000;2:505-513.
57. Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance MA, Saunders AM: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-530.
58. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000;20:5709-5714.
59. Weggen S, Eriksen JL, Sagi S A, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH: Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity. J Biol Chem 2003; 278:31831-31837.
60. Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thai LJ: A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 2000;54:588-593.
61. Belanoff JK, Gross K, Yager A, Schatzberg AF: Corticosteroids and cognition. J Psychiatr Res 2001;35:127-145.